Get App
Download App Scanner
Scan to Download
Advertisement
LIVE UPDATES

Sensex, Nifty End Higher Led By Outperformance In Banks, Pharma

Sensex, Nifty End Higher Led By Outperformance In Banks, Pharma
An employee interprets data from a graph (Photographer: Natalie Behring/Bloomberg)
5 years ago
Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today. 

Indian equity markets ended higher on Tuesday, tracking positive cues from Asia and led by an outperformance in Banking and Pharma stocks.

The S&P BSE Sensex ended 0.74% higher at 39,044 while the NSE Nifty 50 gained 0.7% at the close of trade to end at 11,521.

Banking stocks, which were responsible for the indices ending lower on Monday, outperformed the indices in today's session. The Nifty Bank ended with gains of 1.8% or 400 points.

Pharma stocks were the other outperformers in today's session. The index ended off the highest point of the day, but with gains of nearly 2%.

Most other sectoral indices ended flat in today's session. The realty index was the top laggard, ending with losses of 0.7%.

Broader markets outperformed the benchmarks for the second day running. The midcap index recovered from the day's low to end 1% higher while the smallcap index gained 1.5% as trading came to a close.

India Volatility Index fell 3.75% to 20.4.

Market breadth remained in favour of the gainers. 1,105 stocks on the NSE ended with gains while 713 stocks declined.

The company has informed the exchanges that it has fully repaid all the loans against pledged shares of the company.

"Hence, all the shares held in promoters' account / companies are free from any encumbrance whatsoever," the company said in an exchange filing.

Shares are at the day's high, up as much as 8% to Rs 447.4, the highest level since September 2018.

Shares fell as much as 4% to Rs 1,257.

  • Trades at the highest level in nearly seven months
  • Gains as much as 8% to Rs 751
  • Biggest single-day gain in nearly three months
  • Up for the fifth straight day
  • Longest winning streak since June 2020
  • Has gained 18% in the last five trading sessions
  • Today's volumes are more than double its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 80
  • Trading 8% away from its 52-week high of Rs 804.7 on February 25, 2020
  • 10 out of the 15 analysts tracking the stock have a buy recommendation; 2 sell calls
  • The stock trades 23.3% higher than its 12-month consensus price target of Rs 575.1, implying a negative return potential

CRISIL ratings expects demand for residential real estate in the country to drop by 50-70% in FY21, Bloomberg News reports.

The financial fallout due to Covid-19 is attributed to be one of the major reasons for the same, the rating agency wrote in a note.

CRISIL also expects a correction in real estate prices by 5-15%, the note said, adding that small-to-medium sized developers will face a nearly 200% rise in funding gap this financial year.

"Given the tight liquidity, some of these players will be vying for tie-ups with larger established names," the note said.

  • Reliance Industries' 2,400 Call: Premium up 3.5% to Rs 29.55. The contract has added 66 shares in Open Interest.
  • Infosys' 1,000 Call: Premium up 17% to Rs 15.9. The contract has added 287 shares in Open Interest.
  • Dr Reddy's 4,500 Call: Premium up 58.5% to Rs 125. The contract has shed 309 shares in Open Interest.

  • Trading at the highest level since July 2019
  • Gains as much as 8% to Rs 598
  • Biggest single-day gain in three months
  • Up for the second straight day
  • Has gained 11% in the last two sessions
  • Today's volumes are six times higher than its 20-day average
  • Stock in overbought territory with Relative Strength Index (RSI) at 71
  • Has more than doubled from its 52-week low of Rs 275 on March 24, 2020
  • Four out of the five analysts tracking the stock have a buy recommendation; 0 sell calls
  • The stock trades 2.5% higher than its 12-month consensus price target of Rs 575.4, implying a negative return potential

  • Benchmark indices trade near the day's high
  • Nifty up 0.7% at 11,518
  • Sensex up 0.7% at 39,016
  • Nifty Bank up 0.7% at 22,250
  • Nifty Midcap index up 0.9%
  • Nifty Smallcap index up 0.8%
  • India Volatility Index down 1.8% at 20.8
  • Nifty Pharma index is the top sectoral gainer; up 2.6%
  • Nifty I.T. up for the fourth straight day; up 1.43%
  • Nifty Realty is the top sectoral laggard; down 0.9%
  • Cipla is the top Nifty gainer; up 3.7%
  • Maruti Suzuki is the top Nifty laggard; down 1.2%
  • 1,050 stocks on the NSE trade with gains while 705 decline

  • Top gainer on the Nifty Midcap index
  • Gains as much as 6.6% to Rs 239.1
  • Trades at the highest level in nearly seven months
  • Up for the fourth straight day
  • Longest winning streak in nearly three months
  • Has gained 20% in the last four trading sessions
  • Today's volumes are 96% higher than its 20-day average
  • Rebounded from 50-Day Moving Average support at 198.1
  • Stock entering overbought territory with Relative Strength Index (RSI) at 70
  • Has doubled from its 52-week low of Rs 107.2 on March 26, 2020 and is 10% away from its 52-week high of Rs 267 on February 19, 2020
  • Six out of the seven analysts tracking the stock have a buy recommendation; 1 sell call
  • Return potential of the stock as per Bloomberg data is 5.4%

Nifty Bank: September 17 Expiry
  • 22,000 Put: Premium down 17% to Rs 209.3. The contract has added 19,186 shares in Open Interest.
  • 22,500 Call: Premium down 20% to Rs 170.5. The contract has added 10,902 shares in Open Interest.
  • 21,500 Put: Premium down 22.7% to Rs 79.1. The contract has added 9,930 shares in Open Interest.

The company has informed the exchanges that it has been declared as the L-1 bidder for a State Water and Sanitation Mission project in Uttar Pradesh.

The project involves construction of Kachonda Kalan Group of villages water supply scheme in the Lalitpur district of the state.

The commissioning, operation and maintenance for the project will be for a period of 10 years.

The project is valued at Rs 196 crore, the company said.

Shares gained as much as 5% to Rs 17.9, post the announcement.

The company has informed the exchanges that it has received a Letter of Intent from Epicons Consultants for the construction of a new academic building.

The new academic building is for the South Indian Education Society at TTC Industrial Area, Navi Mumbai, the company said in an exchange filing.

The order, worth Rs 31.57 crore has been awarded on an item rate basis and has to be completed within 12 months from the date of receipt of this Letter of Intent.

Shares gained as much as 2.2% to Rs 9.81, post the announcement.

Let's take a look at how benchmark indices across Europe have opened:

  • Euro Stoxx 50 up 0.3% at 3,326
  • DAX up 0.3% at 13,233
  • CAC up 0.2% at 5,062
  • FTSE 100 up 0.35% at 6,046
  • IBEX 35 up 0.46% at 6,983

  • Among the top performers on the Nifty I.T.
  • Trades at an all-time high
  • Gains as much as 2.5% to Rs 1,252
  • Up for the fourth straight day
  • Longest winning streak in nearly a month
  • Has gained 7% in the last four trading sessions
  • Today's volumes are 96% above its 20-day average
  • Stock nearing overbought territory with Relative Strength Index (RSI) at 68
  • Has more than doubled from its 52-week low of Rs 672.1 on September 16, 2019
  • 15 out of the 36 analysts tracking the stock have a buy recommendation; 12 sell calls
  • The stock trades 16.2% higher than its 12-month consensus price target of Rs 1,046.4, implying a negative return potential

  • Benchmark indices recover from day's low
  • Nifty up 0.5% at 11,493
  • Sensex up 0.5% at 39,938
  • Nifty Bank up 0.8% at 22,265
  • Nifty Midcap index up 0.3%
  • Nifty Smallcap index up 0.8%
  • India Volatility Index down 1.8% to 20.8
  • Nifty Pharma remains the top sectoral gainer; up 2.3%
  • Nifty Realty, PSU Bank and Nifty Auto decline 0.5% each
  • Dr Reddy's Laboratories is the top Nifty gainer; up 3.3%
  • Top three gainers on the Nifty 50 index are Pharma stocks
  • Eicher Motors is the top Nifty laggard; down 1.4%
  • 1,034 stocks on the NSE trade with gains while 684 decline

Shares fell as much as 4.3% to Rs 56.1. The stock has declined in nine out of the last 12 trading sessions.

  • Top gainer on the Nifty 50 index
  • Gains as much as 4.5% to Rs 754
  • Biggest single-day gain in a month
  • Snaps three-day losing streak
  • Had gained only once in the last seven trading sessions
  • Today's volumes are triple its 20-day average
  • Takes support at its 50-Day Moving Average of 713.9 and rebounds
  • Has doubled from its 52-week low of Rs 354.3 on March 13, 2020. However, the stock is 7.3% below its 52-week high of 814.5 on August 10, 2020
  • 35 out of the 42 analysts tracking the stock have a buy recommendation; 1 sell call
  • Return potential of the stock as per Bloomberg data is 7.2%

Shares gained as much as 4.6% to Rs 1,698, before cooling off. The stock is up for the fourth straight day.

28 lakh shares of the company exchanged hands in a single large trade on the Bombay Stock Exchange.

The deal was worth Rs 79 crore as per data available on Bloomberg.

Buyers and sellers in the trade were not known.

Shares gained as much as 5.8% to Rs 283.5. The stock gained the most in three months and is trading at the highest level in nearly seven months. Shares are trading higher for the third straight day.

  • Among the top performers on the Nifty 500 index
  • Gains as much as 9.6% to Rs 197.7
  • Biggest single-day gain in two months
  • Trades at the highest level in eight months
  • Up for the fourth straight day
  • Longest winning streak in over a month
  • Has gained 16% in the last four trading sessions
  • Today's volumes are more than double its 20-day average
  • Rebounds from 50-Day Moving Average of 162.7
  • Stock enters overbought territory with Relative Strength Index (RSI) at 70
  • Has tripled from its 52-week low of Rs 63.8 on March 24, 2020
  • 10 out of the 14 analysts tracking the stock have a buy recommendation; 0 sell calls
  • The stock trades 5% higher than its 12-month consensus price target of Rs 179, implying a negative return potential

Shares fell as much as 2.9% to Rs 130.1. The stock is down for the second straight day and has declined in six out of the last eight trading sessions.

The company at its board meeting on Monday informed that it has decided to sell its entire shareholding in its subsidiary, APA Engineering. The company currently holds 58% stake in the subsidiary.

It has also decided to initiate liquidation proceedings of Navitas Life Sciences GmbH, a unit based in Germany. The company has attributed the external and internal events arising from Covid-19 as the reason behind this move.

"The liquidity and business constraints, consequent to the impact of Covid-19 pandemic, have significantly impacted operations of the step-down subsidiary," the statement said.

Shares fell as much as 11.7% - the most in six months to Rs 43.9 - the lowest level in a month.

The company has informed the exchanges that it has received an export order of nearly 5,100 wheels from the EU Caravan trailer market.

The order is valued at 45,000 Euros and will be executed in the month of October from the company's Chennai plant.

The company anticipates orders of similar capacity from the same customer base.

Shares gained as much as 3.2% to Rs 460.5, post the announcement. The stock is up for the second straight day.

  • Top gainer on the Nifty Smallcap index
  • Gains as much as 7.4% to Rs 445.3
  • Biggest single-day gain in four months
  • Trades at the highest level since February 2019
  • Up for the third straight day
  • Has gained 16% in the last three trading sessions
  • Today's volumes are nearly quadruple its 20-day average
  • Broke above its 50-Day Moving Average of 392.5 on Friday; up 14% since then
  • Has doubled from its 52-week low of Rs 220 on March 25, 2020
  • Nine out of the 10 analysts tracking the stock have a buy recommendation; 1 sell call
  • Return potential of the stock as per Bloomberg data is 8.5%

  • Benchmark indices remain positive but off the day's high
  • Nifty up 0.3% at 11,475
  • Sensex up 0.3% at 38,879
  • Nifty Bank up 0.3% at 22,168
  • Nifty Midcap index up 0.8%
  • Nifty Smallcap index up 0.5%
  • India Volatility Index down 1.8% to 20.81
  • Nifty Pharma is the top sectoral gainer; up 2.3%
  • Nifty Realty is the top sectoral laggard; down 0.5%
  • Most other sectoral indices trade flat
  • Cipla is the top gainer on the Nifty; up 3.3%
  • Top three gainers on the Nifty 50 index are pharma stocks
  • Tech Mahindra is the top Nifty laggard; down 1.7%
  • 1,071 stocks on the NSE trade with gains while 587 decline

The currency opened higher for the second straight day, after recovering from the day's low on Monday to post modest gains.

The rupee opened at 73.37 against the U.S. Dollar as compared to Monday's close of 73.48. The focus today will be on the trade data for the month of August. The country is likely to report a trade deficit of $7 billion in August.

Yield on the 10-year government bond opened at 6.02% as compared to Monday's close of 6.041%.

India's Consumer Price Inflation rose 6.7% in August, reducing the room for further rate cuts from the central bank.

Traders will also watch for the sale of state government bonds worth Rs 12,500 crore.

The lender informed the exchanges on Monday that it has been granted an exemption by the Reserve Bank of India, under the Banking Regulation Act, 1949, with regards to its shareholding above 30% in ICICI Lombard and ICICI Prudential.

The exemption is for a period of three years, until September 2023, the bank said in an exchange filing.

The bank also said that currently it has no plans to divest less than 50% shareholding in ICICI prudential and that there would be no impact on the current distribution arrangements.

The above exemption would facilitate compliance with rules if the proposed acquisition of another general insurance business, made by ICICI Lombard is consummated. The said transaction may bring ICICI Bank's shareholding in ICICI Lombard to less than 50%.

Shares gained as much as 2% to Rs 371, snapping a two-day losing streak.

Shares gained as much as 16.4% - the most since March 2011 to an all-time high of Rs 965. The stock is up for the fourth straight day, the longest streak in nearly two months.

  • Lowest new Covid-19 cases reported in a week
  • 83,809 new case reported in the last 24 hours
  • Total confirmed cases at 49,30,236
  • Active cases at 9,90,061
  • Number of patients cured / discharged / migrated at 38,59,399
  • Death toll rises to 80,776
  • 1,054 deaths reported in the last 24 hours
  • 79,292 patients recovered in the last 24 hours

Shares of the manufacturer and distributor of Indian cusine are gaining at the start of trade after investor Ashish Kacholia purchased stake in the company.

As per data available on the exchanges, Kacholia acquired 0.74% stake in the company at Rs 377.99 pe share.

Shares are locked in an upper circuit of 5% at Rs 399.75 per share. This is the biggest single-day gain seen by the stock in nearly six months.

The stock is up for the second straight day and is trading at a one-month high.

Indian equity markets opened higher, tracking positive cues from Wall Street and mixed ones from the Asia Pacific.

The S&P BSE Sensex opened 0.38% higher at 38,904 while the NSE Nifty 50 index gained 0.4% to 11,487 at the start of trade.

Among the sectoral indices, the Nifty PSU Bank index is the top gainer, opening with gains of 0.7% while indices like Nifty Metal and Nifty Media gained 0.6% each.

Broader markets extended Monday's gains at the start of trade. The midcap index opened 0.6% higher while the smallcap index gained 0.8%.

Market breadth stood in favour of the gainers. 1,146 stocks on the NSE opened with gains while 332 stocks declined.

  • Nifty: Sell 11,550 Call of the September 17 expiry in the range of Rs 40-42. Target of Rs 26-17 and stop loss of Rs 56.
  • Nifty Bank: Sell between 22,225-22,275 fo target of 22,100-22,000 and stop loss of 22,350
  • Buy SRF September futures for target of Rs 4,383 and Rs 4,437; stop loss of Rs 4,311
  • Sell Tata Steel September futures for target of Rs 399.7 and Rs 391.8; stop loss of Rs 410.3
  • Both SRF and Tata Steel are intraday recommendations
  • Source: ICICI Securities

For details on earnings reported after market hours, key brokerage updates and F&O cues, click here.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search